全球人工心臟瓣膜市場 - 市場規模（依細分市場）、佔有率、監管、償付、治療、預測（~2033年）

世界各地老年人口的增加以及隨之而來的心臟瓣膜惡化是人工心臟瓣膜市場的主要驅動因素。瓣膜性心臟病的盛行率隨著年齡的成長而增加。根據嚴重程度，心臟瓣膜疾病可以透過手術修復或人工心臟瓣膜置換來治療。

本報告研究和分析了全球人造心臟瓣膜市場，提供了有關主要參與者和市場佔有率、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的主要內容如下。

人工心臟瓣膜已經上市以及不斷變化的競爭格局

• 對主要產業趨勢的考察
• 人工心臟瓣膜市場各細分市場的年收入及市場前景（2015-2033年）
• 依細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細資料

全球、區域和國家層面的特定市場考察

• 依地區細分全球趨勢的特定市場定性資訊和國家考察
• 人工心臟瓣膜市場的SWOT分析
• 人工心臟瓣膜市場競爭動態的考察與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場理解。市場進入部分還提供有關償付政策和監管環境的訊息，能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技監理狀況

目標公司

• Edwards Lifesciences Corp
• Abbott Laboratories
• Medtronic Plc
• Corcym UK Ltd
• Artivion Inc
• Lepu Medical Technology (Beijing) Co Ltd
• TTK Healthcare Ltd
• Braile Biomedica Ltda
• 其他

Prosthetic Heart Valves Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Prosthetic heart valves are a device that mimics the function of human heart valves and have a passive mode of functioning; the opening and closing of valves are responses to pressure and flow changes within the heart. Prosthetic heart valves are for patients who have a heart valvular disease where they need their valves to be replaced. Prosthetic heart valves include both Mechanical Heart Valves and Tissue or Biological Heart Valves.

The increase in the aging population across the globe and the associated valvular degeneration is a major driving factor of the Prosthetic Heart Valve market. The prevalence of valvular heart disease increases with age. Depending on the severity of the condition Valvular Heart Diseases can be treated by surgical repair or replacement procedures using prosthetic heart valves.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Prosthetic Heart Valves market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Prosthetic Heart Valves market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Prosthetic Heart Valves market.
• Competitive dynamics insights and trends provided Prosthetic Heart Valves market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, Braile Biomedica Ltda, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Prosthetic Heart Valves marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Prosthetic Heart Valves market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Prosthetic Heart Valves market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Prosthetic Heart Valves market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.